Leveraging real-time insights into the current priorities of cardiologists through TCROSS NEWS, a cardiovascular-focused information platform, TCROSS provides end-to-end support from strategic planning and content creation to distribution and research.
TCROSS NEWS has more than 9,000 registered physicians, including approximately 7,500 hospital-based cardiologists. This represents nearly 70% of the estimated 11,000 hospital-based cardiologists nationwide in Japan, making it a highly trusted platform among leading clinicians on the frontlines of cardiovascular care.
We deliver approximately 1,300 pieces of cardiovascular-focused content annually, maintaining a 97% satisfaction rate among paid members, and an email newsletter open rate of around 40%. In addition, institutional subscriptions are steadily expanding.
Based on trends, data, and real-world clinical insights in the cardiovascular field, we conduct proprietary quantitative analyses that classify cardiologists into five distinct segments. By capturing multiple dimensions, including specialty area, fields of interest, responsiveness to information, and clinical phase, we enable highly refined targeting and message design optimized for each segment.
We propose optimal marketing strategies based on TCROSS NEWS usage data.
Our dedicated professional writing team produces reliable articles and videos in full compliance with relevant clinical guidelines.
We support content promotion through the strategic alignment of messaging with the key interests of cardiologists across subspecialties, including ischemia, heart failure, and arrhythmia.
From questionnaire design and survey distribution to target physicians through to results analysis, we deliver actionable research that leads to the next step.
Astellas Pharma Inc.
Abbott Medical Japan LLC
Kaneka Medix Corporation
Shimadzu Corporation
Johnson & Johnson K.K.
Zeon Medical Inc.
Daiichi Sankyo Company, Limited
Takeda Pharmaceutical Company Limited
Terumo Corporation
Nipro Corporation
Nihon Biosensors Inc.
Nippon Boehringer Ingelheim Co., Ltd.
Medtronic Japan Co., Ltd.
Novartis Pharma K.K.
Pfizer Japan Inc.
Boston Scientific Japan K.K.
…and others